Clinical Trial: Treatment response assessment for breast cancer after neoadjuvant therapy with post-treatment MRI using annotation-free foundation model (China)

China, Sept. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Treatment response assessment for breast cancer after neoadjuvant therapy with post-treatment MRI using annotation-free foundation model'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132742

Registration Time: 2026/09/17

Type: Diagnostic test

Primary Sponsor: Yunnan Cancer Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=335603

Published by HT Digital Content Services with permission from Health Daily Digest....